Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) Net Income towards Common Stockholders (2016 - 2026)

Cryo Cell International's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $47108.0 for Q1 2026.

  • Quarterly results put Net Income towards Common Stockholders at $47108.0 for Q1 2026, down 83.35% from a year ago — trailing twelve months through Feb 2026 was -$2.7 million (down 2170.66% YoY), and the annual figure for FY2025 was -$2.4 million, down 704.18%.
  • Net Income towards Common Stockholders for Q1 2026 was $47108.0 at Cryo Cell International, up from -$3.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.1 million in Q3 2024 to a low of -$11.2 million in Q4 2023.
  • The 5-year median for Net Income towards Common Stockholders is $556241.0 (2024), against an average of -$513555.5.
  • The sharpest move saw Net Income towards Common Stockholders crashed 1435.61% in 2023, then soared 196.77% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at $837822.0 in 2022, then crashed by 1435.61% to -$11.2 million in 2023, then surged by 83.36% to -$1.9 million in 2024, then crashed by 105.06% to -$3.8 million in 2025, then soared by 101.23% to $47108.0 in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $47108.0, -$3.8 million, and $749408.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.